Reporting person on SEC Form 4

Kimberlee C Drapkin

Kimberlee C Drapkin is Director at Lenz Therapeutics. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 16, 2026, each linked to the official Form 4.

Director

Disclosures on record

1

Companies involved

1

Disclosure history

Lenz TherapeuticsLENZ
Jun 15, 202622Kdisclosed Jun 16
Details Official record